Irbesartan Generis

Irbesartan, the active ingredient in Irbesartan Generis, is a Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is used to manage high blood pressure, protect kidney function in diabetic patients, and support treatment of heart failure.

GNH USA supplies Irbesartan Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under strict GMP conditions.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to lower blood pressure and reduce organ damage.

- Hypertension: lowers systolic and diastolic pressure, decreasing cardiovascular risk. - Diabetic nephropathy: slows progression of kidney disease in patients with type 2 diabetes. - Heart failure: reduces afterload and fluid retention, improving functional status.

Irbesartan may cause unwanted reactions that vary in frequency.

Common Side Effects: - Dizziness - Headache - Fatigue - Nausea - Hyperkalemia - Cough

Serious or Rare Side Effects: - Angioedema - Severe hypotension - Acute kidney injury - Hepatic dysfunction - Life‑threatening hyperkalemia - Myocardial infarction

Before initiating therapy, certain precautions should be observed.

- Monitor blood pressure: ensure adequate control and avoid excessive lowering. - Assess renal function: check serum creatinine and eGFR prior to start and periodically thereafter. - Check serum potassium: hyperkalemia risk requires regular monitoring. - Avoid use in pregnancy: drug is contraindicated due to fetal toxicity. - Use with caution in elderly or hepatic impairment: dose may need adjustment. - Store at room temperature: keep in the original pack, protect from moisture.

Irbesartan can interact with other medicines, influencing safety or effectiveness.

Major Interactions (Avoid): - Aliskiren (in patients with diabetes): combined use increases risk of renal impairment and hyperkalemia. - ACE inhibitors or direct renin inhibitors: additive effect on potassium and renal function. - Potassium‑sparing diuretics: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs: can blunt antihypertensive effect and affect renal function. - Lithium: may raise lithium concentrations, risking toxicity. - Cyclosporine or azole antifungals: can increase irbesartan plasma levels, requiring dose review.